Topics

Companies Related to "bluebird Appoints Joanne Smith Farrell Chief Business Officer" [Most Relevant Company Matches] RSS

11:08 EDT 21st September 2019 | BioPortfolio

Here are the most relevant search results for "bluebird Appoints Joanne Smith Farrell Chief Business Officer" found in our extensive corporate database of over 50,000 company records.

Showing "bluebird Appoints Joanne Smith Farrell Chief Business Officer" Companies 1–25 of 5,300+

Extremely Relevant

REVOLUTION Medicines

The REVOLUTION Medicines team brings deep expertise and a track record of building exceptional life sciences companies. In addition to Dr. Goldsmith, founding president and chief executive officer and Dr. Burke, founder and scientific advisory board chairman, the team includes: David Pompliano, Ph.D., founding chief scientific officer, who is a leading ...


Vantage Oncology, LLC

Founded in October 2002, Manhattan Beach, California-based Vantage Oncology, LLC owns, operates and manages radiation oncology centers of excellence. The company’s founding principles were to address the growing need among cancer patients, hospitals and physicians for easily accessible and advanced radiation treatment therapies. Vantage Oncology curre...

Vantage Oncology

Founded in October 2002, Vantage Oncology acquires, joint ventures, develops and operates radiation oncology centers of excellence. The Company was created in response to the growing need among cancer patients, hospitals and physicians for accessible and advanced radiation treatment therapies. Recent developments at Vantage include the establishment of multi-specialty oncology care organizations ...


Relevant

Origo Acquisition Corporation

Origo Acquisition Corporation is a public investment vehicle formed for the purpose of effecting a merger, acquisition or similar business combination. Origo is led by Chief Executive Officer Edward J. Fred, Chief Financial Officer Jose M. Aldeanueva and Directors Stephen B. Pudles, Jeffrey J. Gutovich and Barry Rodgers. Origo’s securities are quoted ...

TScan Therapeutics

David Southwell, Chief Executive Officer David Southwell is the Chief Executive Officer of TScan and also serves as a member of the Company’s Board of Directors. Previously, David served as President and Chief Executive Officer of Inotek Pharmaceuticals through Inotek’s merger with Rocket Pharmaceuticals, a gene therapy-based biotechnology company. Previously, Mr. Southwell served as Ex...

MARVAL O´FARRELL & MAIRAL

MARVAL O´FARRELL & MAIRAL is the largest and one of the oldest law firms in Argentina; it dates back to 1923 when it was founded as an office specifically dedicated to intellectual property law by two brothers, J.A. & E. de Marval. In 1938, when Jorge E. O'Farrell (1915-2000) joined the firm, its activities were extended to include the provision of legal services and the name of the firm was chan...

Sucampo Pharmaceuticals, Inc. and Takeda

Sucampo Pharmaceuticals, Inc., an international pharmaceutical company, is focused on the discovery, development and commercialization of proprietary drugs based on prostones. The therapeutic potential of prostones, which occur naturally in the human body as a result of enzymatic (15-PGDH) transformation of certain fatty acids, was first identified by Ryuj...

Vmersion-Health

Vmersion-Health, developer of Gluco-Share, is a California Limited Partnership founded in 2011. Vmersion-Health develops and publishes social media applications for health-related causes, with a commitment to improved health through better communication and social support mechanisms. Joseph “Joe” Madden is president and Chief Executive Officer; J...

Cox Smith Matthews Incorporated

Cox Smith is one of the leading business law firms in Texas. From its dominant position in San Antonio with a growing presence in key markets, Cox Smith's attorneys help regional, national and international businesses with a wide variety of matters involving all aspects of business law and litigation. For more information, visit www.coxsmith.com.

bluebird bio, Inc. bluebird bio to Present Updated Clinical Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti- BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASCO Annual Meeting

Sucampo Pharmaceuticals, Inc. and Numab AG

Sucampo Pharmaceuticals, Inc., an international pharmaceutical company based in Bethesda, Maryland, is focused on the discovery, development and commercialization of proprietary drugs based on prostones. The therapeutic potential of prostones which occur naturally in the human body as a result of enzymatic (15-PGDH) transformation of certain fatty acids wa...

Sucampo Pharmaceuticals, Inc. and Abbott

Sucampo Pharmaceuticals, Inc., an international biopharmaceutical company based in Bethesda, Maryland, focuses on the development and commercialization of medicines based on prostones. The therapeutic potential of prostones, which occur naturally in the human body as a result of enzymic (15-PGDH) transformation of certain fatty acids, was first identified ...

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc.

Sucampo Pharmaceuticals, Inc. is a global pharmaceutical company focused on innovative research, discovery, development and commercialization of proprietary drugs based on prostones. The therapeutic potential of prostones, which occur naturally in the human body as a result of enzymatic (15-PGDH) transformation of certain fatty acids, was first identified ...

MedDay

MedDay is a privately held biotechnology company developing new drugs for nervous system disorders. The company was founded in 2011 by Frédéric Sedel, MD, PhD (Chief Executive Officer), a leading neurologist and neuroscientist; and Guillaume Brion, MD (Chief Operating Officer) who has 25 years of experience in drug development and clinical research i...

Harbinger Capital Partners

Harbinger Capital Partners is a multi-billion dollar private investment fund based in New York which employs a fundamental, intensive research-based approach to investing. Harbinger Capital Partners is led by Phil Falcone who has been the Chief Executive Officer and Chief Investment Officer of funds affiliated with or managed by Harbinger Capital Partners ...

bluebird bio, Inc.

bluebird bio is developing innovative gene therapies for severe genetic disorders. At the heart of bluebird bio’s product creation efforts is its broadly applicable gene therapy platform for the development of novel treatments for diseases with few or no clinical options. The company’s novel approach uses stem cells harvested from the patientâ...

IntraBiotics Pharmaceuticals Inc.

On June 20, 2005, IntraBiotics Pharmaceuticals, Inc. announced that the Company was terminating all regular employees and ceasing all operations. It was also announced that the Company was appointing Hickey & Hill, Inc. to assume responsibilities for the day-to-day administration of the Company and that Mr. Hickey was to be designated Chief Executive Officer. Mr. Hickey has since been appointed Ch...

Greater Medical Center Group

The Greater Medical Center Group (GMCG) is a provider of U.S. Clerkships for International Medical Students and Graduates. As a network of professionals and educators, GMCG's mission is to standardize the clinical experience of medical students educated abroad while providing support services to international medical schools. Key executives are Dr. Stephen M. Cohen, Chief Executive Officer; ...

Interface Biologics

Toronto, Canada – August 26, 2005 - Interface Biologics Inc. announced today the appointment of Richard W. Sullivan to the position of President and Chief Executive Officer of the Company.Mr. Sullivan brings more than 30 years of senior management and executive experience in the life sciences industry, having held key positions in early stage corporations since 1990. Most recently, as Chief Exec...

AmeriLithium Corp.

Matthew Worrall, Chief Executive Officer

Palo Alto Investors, LLC

By: /s/ Will EdwardsName: Will Edwards, Chairman and Chief Investment Officer

University of Maryland's Robert H. Smith School of Business

The Robert H. Smith School of Business is an internationally recognized leader in management education and research. One of 13 colleges and schools at the University of Maryland, College Park, the Smith School offers undergraduate, full-time and part-time MBA, executive MBA, MS in business, PhD and executive education programs, as well as outreach services to the corporate community. The school of...

Medivizor

Medivizor offers a patent-pending, personalized health information platform for individuals with serious or chronic illnesses. Users of Medivizor are benefiting from custom content, cutting-edge research, clear and authoritative descriptions of treatment options, individual-matched clinical trials, social engagement, and much more. Professor Steven ...

G & W Laboratories,Inc.

Carl Greenblatt founded G & W Laboratories, Inc. over eighty years ago upon his return from military service as a pharmacist with US forces in World War I. While establishing a reputation as an innovative specialist in suppository dosage forms, Carl guided G & W Laboratories with an uncompromising commitment to product integrity and customer service. In 1945, Carl's son, Burton, also a registered ...

Smith & Nephew Inc.

Smith & Nephew is a global medical technology business, specializing in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies, Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.


More From BioPortfolio on "bluebird Appoints Joanne Smith Farrell Chief Business Officer"

Quick Search

Corporate Database Quicklinks